AU Stock MarketDetailed Quotes

ACL Australian Clinical Labs Ltd

Watchlist

3.770
+0.100+2.72%

20min DelayNot Open Oct 1 16:00 AET

760.91MMarket Cap31.42P/E (Static)

Australian Clinical Labs Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Operating cash flow (direct method)

Cash income from operating activities

-3.35%694.68M

-27.42%718.73M

49.59%990.24M

661.97M

Revenue from customers

-3.35%694.68M

-27.42%718.73M

49.59%990.24M

--661.97M

Cash paid

6.39%-508.76M

13.17%-543.47M

-39.03%-625.93M

-450.22M

Payments to suppliers for goods and services

6.39%-508.76M

13.17%-543.47M

-39.03%-625.93M

---450.22M

Direct interest paid

-20.41%-16.67M

-21.55%-13.85M

71.08%-11.39M

---39.39M

Direct interest received

175.27%501K

304.44%182K

-40.00%45K

--75K

Direct tax refund paid

43.29%-10.16M

74.00%-17.91M

-271.00%-68.87M

---18.56M

Operating cash flow

11.07%159.59M

-49.42%143.68M

84.64%284.09M

--153.86M

Investing cash flow

Cash flow from continuing investing activities

40.51%-7.25M

83.09%-12.18M

-1,085.70%-72.04M

-6.08M

Net PPE purchase and sale

7.73%-6.18M

68.07%-6.7M

-123.32%-20.98M

---9.39M

Net business purchase and sale

---1.07M

----

Net investment purchase and sale

----

--1.07M

Net other investing changes

----

89.26%-5.48M

-2,367.50%-51.06M

--2.25M

Cash from discontinued investing activities

Investing cash flow

40.51%-7.25M

83.09%-12.18M

-1,085.70%-72.04M

---6.08M

Financing cash flow

Cash flow from continuing financing activities

-5.99%-146.14M

37.59%-137.88M

-49.90%-220.91M

-147.37M

Net issuance payments of debt

-116.67%-11M

166.00%66M

-292.27%-100M

--52.01M

Net common stock issuance

-95.51%-1.74M

81.98%-891K

-103.38%-4.94M

--146.25M

Cash dividends paid

79.01%-20.34M

-299.03%-96.88M

42.19%-24.28M

---42M

Net other financing activities

-6.55%-113.06M

-15.73%-106.11M

69.80%-91.69M

---303.63M

Cash from discontinued financing activities

Financing cash flow

-5.99%-146.14M

37.59%-137.88M

-49.90%-220.91M

---147.37M

Net cash flow

Beginning cash position

-24.33%19.96M

-25.15%26.37M

1.10%35.23M

--34.85M

Current changes in cash

197.32%6.21M

28.07%-6.38M

-2,221.05%-8.87M

--418K

Effect of exchange rate changes

37.50%-25K

-900.00%-40K

114.71%5K

---34K

End cash Position

30.97%26.14M

-24.33%19.96M

-25.15%26.37M

--35.23M

Free cash from

11.95%153.09M

-47.97%136.75M

82.07%262.84M

--144.36M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities	-3.35%694.68M	-27.42%718.73M	49.59%990.24M	661.97M
Revenue from customers	-3.35%694.68M	-27.42%718.73M	49.59%990.24M	--661.97M
Cash paid	6.39%-508.76M	13.17%-543.47M	-39.03%-625.93M	-450.22M
Payments to suppliers for goods and services	6.39%-508.76M	13.17%-543.47M	-39.03%-625.93M	---450.22M
Direct interest paid	-20.41%-16.67M	-21.55%-13.85M	71.08%-11.39M	---39.39M
Direct interest received	175.27%501K	304.44%182K	-40.00%45K	--75K
Direct tax refund paid	43.29%-10.16M	74.00%-17.91M	-271.00%-68.87M	---18.56M
Operating cash flow	11.07%159.59M	-49.42%143.68M	84.64%284.09M	--153.86M
Investing cash flow
Cash flow from continuing investing activities	40.51%-7.25M	83.09%-12.18M	-1,085.70%-72.04M	-6.08M
Net PPE purchase and sale	7.73%-6.18M	68.07%-6.7M	-123.32%-20.98M	---9.39M
Net business purchase and sale	---1.07M	----	----	----
Net investment purchase and sale	----	----	----	--1.07M
Net other investing changes	----	89.26%-5.48M	-2,367.50%-51.06M	--2.25M
Cash from discontinued investing activities
Investing cash flow	40.51%-7.25M	83.09%-12.18M	-1,085.70%-72.04M	---6.08M
Financing cash flow
Cash flow from continuing financing activities	-5.99%-146.14M	37.59%-137.88M	-49.90%-220.91M	-147.37M
Net issuance payments of debt	-116.67%-11M	166.00%66M	-292.27%-100M	--52.01M
Net common stock issuance	-95.51%-1.74M	81.98%-891K	-103.38%-4.94M	--146.25M
Cash dividends paid	79.01%-20.34M	-299.03%-96.88M	42.19%-24.28M	---42M
Net other financing activities	-6.55%-113.06M	-15.73%-106.11M	69.80%-91.69M	---303.63M
Cash from discontinued financing activities
Financing cash flow	-5.99%-146.14M	37.59%-137.88M	-49.90%-220.91M	---147.37M
Net cash flow
Beginning cash position	-24.33%19.96M	-25.15%26.37M	1.10%35.23M	--34.85M
Current changes in cash	197.32%6.21M	28.07%-6.38M	-2,221.05%-8.87M	--418K
Effect of exchange rate changes	37.50%-25K	-900.00%-40K	114.71%5K	---34K
End cash Position	30.97%26.14M	-24.33%19.96M	-25.15%26.37M	--35.23M
Free cash from	11.95%153.09M	-47.97%136.75M	82.07%262.84M	--144.36M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data